Clinical Trials Logo
  1. Home
  2. Other
  3. NCT01969890

STem cElls Mobilization in Acute Myocardial Infarction Outcome Trial — STEM-AMI  

Left Ventricular Systolic Dysfunction Clinical Trial

Official title:
Phase III Study on STem cElls Mobilization in Acute Myocardial Infarction

Clinical Trial Summary

The purpose of this study is to demonstrate that granulocyte colony-stimulating factor (G-CSF) therapy in addition to state-of-the-art treatment (pharmacological and non pharmacological) is safe and significantly improves clinical outcome in patients with reduced left ventricular ejection fraction (LVEF) (≤45%) after successful reperfusion for large anterior acute myocardial infarction.

Clinical Trial Description

Post infarction heart failure (HF) remains a major cause of morbidity and mortality. In the United States, more than three million patients, and 700.000 in Italy, have cardiac failure and its most common cause is ischemic heart disease. The major goal to improve post infarction LV function would be the stimulation of neovascularization and the enhancement of regeneration of cardiac myocytes within the infarcted area. Recent experimental studies suggest that bone marrow-derived progenitor cells (BMCs) or circulating endothelial progenitor cells (cEPCs) contribute to the regeneration of infarcted myocardium, to enhance neovascularization of ischemic myocardium, to prevent cardiomyocyte apoptosis, to alter scar formation by reducing the development of myocardial fibrosis and, thereby, to improve cardiac function. G-CSF is a hematopoietic cytokine produced by monocytes, fibroblasts and endothelial cells. G-CSF is known to have multiple functions in normal, steady-state hematopoiesis. It is routinely used to mobilize CD34+ hematopoietic stem cells from the BM into peripheral blood, thus enabling their easier collection compared to BM aspirate procedure. The proven efficacy and safety of G-CSF, both in healthy donors and patients with haematological disease, along with favourable results from studies of CD34+ cell transplantation in patients with MI or ischemia, suggest that G-CSF based BMC transplantation may have an efficacy in patients with MI. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01969890
Study type Interventional
Source Heart Care Foundation
Contact
Status Terminated
Phase Phase 3
Start date October 2013
Completion date May 2018
View Details
See also
  Status Clinical Trial Phase
Active, not recruiting NCT01058837 - SCD-HeFT 10 Year Follow-up N/A
Completed NCT00752752 - The Acute Cardiovascular Effects of Marathon Running Using Magnetic Resonance Imaging N/A
Recruiting NCT04166331 - Adjunctive DobutAmine in sePtic Cardiomyopathy With Tissue Hypoperfusion Phase 3
Active, not recruiting NCT05764109 - Adherence to Cied Implantation Guidelines and Cardiac Rehabilitation
Completed NCT05630170 - The SMART-LV Pilot Study N/A
Recruiting NCT01747187 - Cardiac Stress in Septic Shock - Biomarkers, Echocardiography and Outcome N/A
Completed NCT01162083 - Identifying an Ideal Cardiopulmonary Exercise Test Parameter N/A
Completed NCT04221763 - Mechanisms and Innovations in Cardiac Resynchronisation Therapy N/A
Recruiting NCT06221891 - Early Evaluation of Left Ventricular Systolic Function Impairment in Patients With Chronic Kidney Disease by Multimodal Ultrasonography
Completed NCT04231331 - Ertugliflozin for Functional Mitral Regurgitation Phase 3
Completed NCT01500759 - Sleep-Disordered Breathing in Heart Failure - The SchlaHF-Registry
Recruiting NCT05714085 - Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036) Phase 2/Phase 3
Completed NCT01086124 - Objective Systolic Function Recuperation Assessed by Echocardiography N/A
Recruiting NCT06270498 - Effect of Oral sucRosomIal Iron on exerciSE Capacity and Quality of Life in Patients With Heart Failure Phase 4
Completed NCT03470155 - Operative Mitral Valve Reconstruction in Functional mv Insufficiency With Reduced Systolic Ventricle Function
Suspended NCT03755570 - How is COGNItive Function Affected by Cardiac Resynchronisation Therapy?
Recruiting NCT04399447 - Multicenter Normal Reference Study of Tissue Motion Tracking of Mitral Annular Displacement(TMAD)
Not yet recruiting NCT03993730 - Cardiovascular Magnetic Resonance GUIDEd Insertion of Implantable Cardiac Defibrillator in Dilated CardioMyopathy N/A
Active, not recruiting NCT01918215 - Cardiac Magnetic Resonance GUIDEd Management of Mild-moderate Left Ventricular Systolic Dysfunction. N/A
Completed NCT02851745 - Effects of Linagliptin on Left Ventricular Myocardial DYsfunction in Patients With Type 2 DiAbetes Mellitus and Concentric Left Ventricular Geometry Phase 3